US Patent Issued to UCB Pharma on July 15 for "N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis" (Belgian, German, Chinese, Egyptian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,875, issued on July 15, was assigned to UCB Pharma GMBH (Monheim, Germany).

"N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis" was invented by Cecile Pegurier (Brussels), Silvia Lovera (Brussels), Christa E. Mueller (Bonn, Germany), Joerg Hockemeyer (Bonn, Germany), Mahmoud Rashed (Cairo), Ali El-Tayeb (Bonn, Germany) and Yong-Qiang Zhang (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are N-(phenyl)-1H-indole-3-sulfonanmide and N-(phenyl)-1H-pyrrolo[2,3-b]pyridine-3-sulfonamide derivatives of formula I substituted at the 1- and 6-pos...